Qube Research & Technologies (QRT)
OTLK icon

Qube Research & Technologies (QRT)’s Outlook Therapeutics OTLK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,347
Closed -$14.1K – 3965
2025
Q3 		$14.1K Sell
13,347
-14,244
-52% -$24.6K ﹤0.01% 3318
2025
Q2 		$44.1K Buy
+27,591
New +$44K ﹤0.01% 3171
2025
Q1 		– Sell
-13,510
Closed -$25.5K – 3772
2024
Q4 		$25.5K Buy
+13,510
New +$55.6K ﹤0.01% 3164
2021
Q1 		– Sell
-1,169
Closed -$30K – 2283
2020
Q4 		$30K Buy
+1,169
New +$24.4K ﹤0.01% 1716

Other funds holding OTLK

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OTLK Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Outlook Therapeutics (OTLK) in Q4 2025, closing a stake of 13,347 shares — an estimated $14.1K sold.

Qube Research & Technologies (QRT) first reported a position in OTLK in Q4 2020 and held it in 4 quarters. The position peaked at $44.1K in Q2 2025. 53 funds tracked by Wall St. Rank hold OTLK as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Outlook Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 13,347 Outlook Therapeutics shares in Q4 2025, an estimated $14.1K.
  • Qube Research & Technologies (QRT) first reported a position in Outlook Therapeutics in Q4 2020 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Outlook Therapeutics position peaked at $44.1K in Q2 2025.
  • 53 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.